| Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
|---|
| 04/29/2009 | EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia |
| 04/29/2009 | CN101417942A Method for preparing p-hydroxymandelic acid |
| 04/29/2009 | CN100482636C Process for preparation of substituted octanoyl amides |
| 04/29/2009 | CN100482632C Preparation of (R)-2-alkyl-3-phenylpropionic acids |
| 04/28/2009 | US7524886 L-(−)-moprolol L-(+)-tartrate |
| 04/23/2009 | WO2009052341A1 Gsm intermediates |
| 04/23/2009 | WO2009052334A1 Carbon linked modulators of y-secretase |
| 04/23/2009 | WO2009051948A1 Biphenyl carboxylic acids and derivatives thereof |
| 04/23/2009 | WO2007062276A3 Continuous flow biodiesel processor |
| 04/23/2009 | US20090105344 Biphenyl carboxylic acids and derivatives thereof |
| 04/23/2009 | US20090105288 CARBON LINKED MODULATORS OF gamma-SECRETASE |
| 04/23/2009 | US20090104559 Bottom Antireflective Coating Compositions |
| 04/23/2009 | US20090104322 Stabilization of dicarbonate diesters with protonic acids |
| 04/23/2009 | CA2702959A1 Carbon linked modulators of .gamma.-secretase |
| 04/23/2009 | CA2702911A1 Gsm intermediates |
| 04/23/2009 | CA2702832A1 Biphenyl carboxylic acids and derivatives thereof |
| 04/22/2009 | EP2050733A1 Method for purifying hydroxycarboxylic acid, method for producing cyclic ester, and method for producing polyhydroxycarboxylic acid |
| 04/22/2009 | EP1285908B9 Substituted phenylpropionic acid derivatives |
| 04/22/2009 | CN101412670A Method for synthesizing loxoprofen sodium |
| 04/22/2009 | CN101412669A Method for producing lactic acid by hydrothermal degradation of biomass wastes |
| 04/22/2009 | CN101412668A 3-acryloyl chloride derivative and preparation thereof |
| 04/22/2009 | CN101412658A Method for saponification and acidolysis of hydrogenated castor oil by using high concentration acid and alkali |
| 04/22/2009 | CN100480232C L-(-)-moprolol l-(+)-tartrate |
| 04/21/2009 | US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia |
| 04/16/2009 | WO2009048527A1 Substituted biphenyl gpr40 modulators |
| 04/16/2009 | WO2008134668A3 Heat-labile prodrugs |
| 04/16/2009 | WO2008099413A3 High purity (-) hydroxycitric acid metal salt derivatives and method of preparation of the same |
| 04/16/2009 | US20090095681 P-tert-butylcalix[6]arenes with triacidic functions at 2, 4 and 6, supported liquid membranes and support materials comprising the same and use thereof |
| 04/15/2009 | EP2046716A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof |
| 04/15/2009 | EP2046715A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof |
| 04/15/2009 | EP2046714A2 Therapeutic compounds |
| 04/15/2009 | CN101410362A Lipid derivatives |
| 04/15/2009 | CN101407454A Process for preparing citrate salt from mother liquor for citric acid production |
| 04/15/2009 | CN101407453A A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide |
| 04/14/2009 | US7518022 High-quality; suitable as a raw material for cosmetics; good retention of liquidity and is unlikely to become cloudy on change of temperature |
| 04/14/2009 | CA2595907C Creatine hydroxycitric acid salts and methods for their production and use in individuals |
| 04/09/2009 | WO2009044251A2 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 04/09/2009 | US20090093650 Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylamines |
| 04/09/2009 | US20090093484 Novel compounds, their preparation and use |
| 04/09/2009 | US20090092580 Dialkyl ether delivery agents |
| 04/09/2009 | CA2701713A1 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 04/08/2009 | CN101402562A Novel benzophenone derivatives or salts thereof |
| 04/08/2009 | CN101402561A Racemization method for L-naproxen |
| 04/08/2009 | CN101402560A Production process for separating and purifying naproxen with crystallization |
| 04/08/2009 | CN101402559A Purification method for D, L-naproxen |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475969C Cytochrome C oxidase enzyme complex |
| 04/07/2009 | CA2447803C Synthesis of 4-phenylbutyric acid |
| 04/07/2009 | CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/07/2009 | CA2343962C Process for preparing carboxylic acids |
| 04/02/2009 | WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders |
| 04/02/2009 | WO2008005451A3 Optical apparatus and methods for chemical analysis |
| 04/02/2009 | US20090088589 reacting glycerin in an alkaline solution consisting sodium hydroxide and water to a hydrothermal reaction; glycerin produced from plant fats, animal fats; hydrogen gas by-product for use in a fuel battery |
| 04/01/2009 | CN100473667C Photoinitiator, novel compound and photocurable composition |
| 04/01/2009 | CN100473637C Rare earth metal compound in aqueous solvent, method for producing the same, and method for producing ceramic powder using the same |
| 03/31/2009 | CA2356121C Novel propargylether derivatives |
| 03/26/2009 | US20090082540 Hydrolysable linkers and cross-linkers for absorbable polymers |
| 03/25/2009 | EP2039673A1 Aqueous solutions of organic acid chromium(iii) salts and process for preparation thereof |
| 03/25/2009 | EP1296935B1 Process for the preparation of substituted octanoyl amides |
| 03/25/2009 | CN100471832C Compound for preparing protease inhibitor |
| 03/24/2009 | US7507833 e.g. 5-(3-(2-(4-(1-hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension |
| 03/24/2009 | US7507421 From aqueous extract of Garcinia cambogia/indica fruits; tasteless; for use in foods |
| 03/24/2009 | CA2437501C Process for the manufacture of phenylacetic acid derivatives |
| 03/19/2009 | US20090076114 Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes |
| 03/19/2009 | CA2698944A1 Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 03/18/2009 | EP2036879A1 Process For Converting A Hydroxy Carboxylic Acid Or Salts Thereof, To An Unsaturated Carboxylic Acid And/Or Its Esters |
| 03/18/2009 | EP1805129B1 (biphenyl) carboxylic acids and derivatives thereof |
| 03/18/2009 | CN100469750C Method of extracting calcium gluconate from mother liquid after calcium gluconate crystallization |
| 03/17/2009 | US7504532 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation |
| 03/12/2009 | WO2009030059A1 Dimethylcyclohexyl derivatives as malodor neutralizers |
| 03/12/2009 | WO2008148549A3 Novel reaction with a gold catalyst |
| 03/12/2009 | US20090070902 Production of hydroxylated fatty acids in genetically modified plants |
| 03/12/2009 | US20090069591 Calcium Bis [ (2S) -3- [3-[ (2S) -3- (4-Chloro-2-Cyanophenoxy) -2- Fluoropropoxy]Phenyl] -2- Isopropoxypropionate] and Intermediate Thereof |
| 03/12/2009 | US20090069589 Efficient cost effective production of HFC-134a and HFC-125 from e.g. 1,1,1,2,2-pentachloroethane using SiF4 and AlCl3 |
| 03/12/2009 | CA2698847A1 Bis-aromatic compounds useful in the treatment of inflammation |
| 03/11/2009 | EP1516624B1 Method of producing calcium gluconolactate, compositions, processes and uses of same |
| 03/11/2009 | CN101381351A Method for cogeneration of 5-hydroxymethyl-furfural, acetylpropionic acid and formic acid by high temperature catalytic dehydration of glucose in formic acid |
| 03/11/2009 | CN101381300A Method for synthesizing 2,2-bis(hydroxymenthyl)propinonic acid |
| 03/11/2009 | CN101381299A Method for synthesizing 2,2-bis(hydroxymenthyl)butyric acid |
| 03/10/2009 | US7501540 Process for producing perfluorodiacyl fluorinated compounds |
| 03/10/2009 | CA2348412C A process for the preparation of alpha-arylalkanoic acids |
| 03/05/2009 | WO2009028608A1 Process for production of phenol derivatives substituted with iodine at ortho position |
| 03/05/2009 | WO2009014471A3 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/04/2009 | EP2029518A2 Cyclopentane-derivatives and their use as ocular hypotensive agents |
| 03/04/2009 | EP2029515A1 Metal complexes comprising a ligand derived from 2-aryl-2-hydroxyacetic acid and a divalent or trivalent metal cation, and their use |
| 03/04/2009 | EP2029507A1 Process for preparing phenoxy acetic acid derivatives |
| 03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | CN100465156C A preparation method of glutamic acid compounds and intermediates thereof and novel intermediates used by the method |
| 03/03/2009 | US7498360 Adminisering prostaglandin into ear |
| 03/03/2009 | CA2335551C Thyroid hormone analogues and methods for their preparation |
| 02/26/2009 | WO2009024707A2 Use of radamea montana extract for preparing a cosmetic composition |
| 02/26/2009 | WO2009024492A1 Leukotriene b4 inhibitors |
| 02/26/2009 | WO2009001046A3 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use |
| 02/26/2009 | US20090054466 Leukotriene B4 Inhibitors |
| 02/26/2009 | US20090053781 chemical synthesis with starting material 1,2-epoxy-3-butene, obtain the intermediate 4-(methylthio)butane-1,2-diol, oxidizing in contact with microbial cell having an ability to convert into 2-hydroxy-4-(methylthio)butyric acid; biosynthesis by Alcaligenes, Bacillus, Pseudomonas, Rhodobacter |
| 02/26/2009 | CA2696967A1 Leukotriene b4 inhibitors |
| 02/25/2009 | EP2027082A1 12-aryl or heteroaryl prostaglandin analogs |
| 02/25/2009 | EP2027081A2 Therapeutic prostaglandin compounds for the treatment of glaucoma |